Armidus Armidus Life Sciences

Animal biology for human health

Discover what other species
reveal about human disease.

Data from animals with naturally occurring disease, from existing records or studies built around your research question.

  • Clinical records
  • Longitudinal outcomes
  • Molecular profiles
Talk to us

Why animal patients

A complement to lab models, NAMs and human research.

Beyond human data

What animal data uncovers that human data can't show.

Naturally occurring disease, intact immune systems and lessons from cross-species differences.

  • Results in months instead of decades

    Progression, recurrence and outcomes often unfold within months.

  • Tissue humans can't easily give

    Diseased, healthy and germline samples from routine care.

  • Differences that reveal new biology

    Why species develop, resist or respond to disease differently can open up new pathways and therapeutic opportunities.

  • A lifetime of disease

    Follow disease from diagnosis through progression, treatment, recurrence and end of life.

Beyond experimental models

Real disease is more than a model.

Lab models and new approach methodologies (NAMs) reproduce parts of a disease, but not the way it develops naturally.

  • Disease that develops naturally

    Engineered and induced models reproduce selected mechanisms. Natural disease emerges through complex processes, often over years.

  • The complete biological system

    Organoids and organ-on-chip systems capture key aspects of human biology, but not yet the interplay of organs, metabolism and immunity in a living organism.

  • Real-world biological diversity

    Lab experiments minimize variability to isolate mechanisms. Naturally diseased animals show disease across genetics, ages, environments and immune histories.

Research

Existing data, or a study built around your question.

Retrospective

Existing records

Consented clinical records, outcomes and samples already collected.

  • Natural history and disease characterization
  • Treatment patterns and outcomes
  • Biomarker and molecular associations
  • Cohort sizing and feasibility

Prospective

Studies to your protocol

We recruit eligible patients through our veterinary partners and collect the data and samples you need.

  • Eligibility screening, including on molecular profile
  • Monitoring between visits through our owner app
  • Samples collected on protocol, linked to outcomes
  • Long-term follow-up by our AI agent

Investigational therapy studies are considered case by case, based on species and disease relevance, study feasibility and appropriate veterinary oversight.

The record

One patient, from baseline to long-term outcome.

  1. Baseline

    Before the study

    • Medical history already on record
    • Stored samples, where available
    • A true pre-study baseline

  2. Between visits

    During the study

    • Symptoms and outcomes reported through our owner app
    • Samples linked to what happened to the animal
    • Clinical and molecular data in one record

  3. Long term

    After the study

    • Our AI agent keeps checking in
    • Survival and late outcomes recorded without extra visits

Responsible research

Consented. Approved. De-identified.

Data privacy policy
  • Retrospective studies: clinic data-sharing agreement and written owner consent
  • Prospective studies: ethics approval and study-specific consent
  • Clinical decisions stay with the treating vet
  • Data de-identified before it reaches you

Contact

Tell us your research question.

Share the disease and what you want to learn. We'll tell you whether existing data covers it, or how a study could.

Please don't include patient records or confidential study data.